United States Pharmaceuticals

Kailera Therapeutics Inc (KLRA)

Track

Track

Kailera Therapeutics Inc recorded significant insider buying activity on April 20, 2026. Major institutional entities and associated individuals acquired substantial equity positions, totaling over 20 million shares. Since these transactions occurred more than three months ago, no recent market movements are discussed regarding this historical capital allocation.
Ticker: KLRA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.7
RTW INVESTMENTS, LP Large shareholder
Transaction date
Purchase
Price
155.47
Quantity 84,618 -13.2%
Value US$4,094,628
4.0
Koppel Adam Non-Executive Director Large shareholder
Transaction date
Purchase
Price
235.50
Quantity 19,285 -16.8%
Value US$3,727,967
3.0
Kaplan Andrew T. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 8,398,438 +47.0%
Value US$134,375,008
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-22 2026-04-20 B Purchase
2.7
RTW INVESTMENTS, LP
Large shareholder
84,618 -13.2%
155.47
US$4,094,628 		84,618 -13.2% 155.47 US$4,094,628
2026-04-20 2026-04-20 B Purchase
2.3
BAIN CAPITAL INVESTORS LLC
Large shareholder
36,356 -48.7%
430.90
US$4,300,214 		36,356 -48.7% 430.90 US$4,300,214
2026-04-20 2026-04-20 B Purchase
4.0
Koppel Adam
Non-Executive Director Large shareholder
19,285 -16.8%
235.50
US$3,727,967 		19,285 -16.8% 235.50 US$3,727,967
2026-04-20 2026-04-20 B Purchase
2.8
Bain Capital Life Sciences Investors, LLC
Large shareholder
1,562,500 +7.4%
16.00
US$25,000,000 		1,562,500 +7.4% 16.00 US$25,000,000
2026-04-20 2026-04-20 B Purchase
3.0
Kaplan Andrew T.
Non-Executive Director Large shareholder
8,398,438 +47.0%
16.00
US$134,375,008 		8,398,438 +47.0% 16.00 US$134,375,008
Explore more

More insider trading research around Kailera Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America